Literature DB >> 19319145

Estimating blood and brain concentrations and blood-to-brain influx by magnetic resonance imaging with step-down infusion of Gd-DTPA in focal transient cerebral ischemia and confirmation by quantitative autoradiography with Gd-[(14)C]DTPA.

Robert A Knight1, Kishor Karki, James R Ewing, George W Divine, Joseph D Fenstermacher, Clifford S Patlak, Tavarekere N Nagaraja.   

Abstract

An intravenous step-down infusion procedure that maintained a constant gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) blood concentration and magnetic resonance imaging (MRI) were used to localize and quantify the blood-brain barrier (BBB) opening in a rat model of transient cerebral ischemia (n=7). Blood-to-brain influx rate constant (K(i)) values of Gd-DTPA from such regions were estimated using MRI-Patlak plots and compared with the K(i) values of Gd-[(14)C]DTPA, determined minutes later in the same rats with an identical step-down infusion, quantitative autoradiography (QAR), and single-time equation. The normalized plasma concentration-time integrals were identical for Gd-DTPA and Gd-[(14)C]DTPA, indicating that the MRI protocol yielded reliable estimates of plasma Gd-DTPA levels. In six rats with a BBB opening, 14 spatially similar regions of extravascular Gd-DTPA enhancement and Gd-[(14)C]DTPA leakage, including one very small area, were observed. The terminal tissue-plasma ratios of Gd-[(14)C]DTPA tended to be slightly higher than those of Gd-DTPA in these regions, but the differences were not significant. The MRI-derived K(i) values for Gd-DTPA closely agreed and correlated well with those obtained for Gd-[(14)C]DTPA. In summary, MRI estimates of Gd-DTPA concentration in the plasma and brain and the influx rate are quantitatively and spatially accurate with step-down infusions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319145      PMCID: PMC4205544          DOI: 10.1038/jcbfm.2009.20

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

2.  Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study.

Authors:  R Bruening; C Berchtenbreiter; N Holzknecht; M Essig; R H Wu; A Simmons; A Heuck; A Maschek; M Meusel; S C Williams; T Cox; M V Knopp; M Reiser
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

3.  Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor.

Authors:  James R Ewing; Stephen L Brown; Mei Lu; Swayamprava Panda; Guangliang Ding; Robert A Knight; Yue Cao; Quan Jiang; Tavarekere N Nagaraja; Jamie L Churchman; Joseph D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  2006-03       Impact factor: 6.200

4.  A method to obtain infusion schedules for prescribed blood concentration time courses.

Authors:  C S Patlak; K D Pettigrew
Journal:  J Appl Physiol       Date:  1976-03       Impact factor: 3.531

Review 5.  The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.

Authors:  Jorge Correale; Andrés Villa
Journal:  Autoimmunity       Date:  2007-03       Impact factor: 2.815

6.  Selection of experimental conditions for the accurate determination of blood--brain transfer constants from single-time experiments: a theoretical analysis.

Authors:  R G Blasberg; C S Patlak; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-06       Impact factor: 6.200

7.  Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA.

Authors:  J Kenney; U Schmiedl; K Maravilla; F Starr; M Graham; A Spence; J Nelson
Journal:  Magn Reson Med       Date:  1992-09       Impact factor: 4.668

8.  Vascular MR contrast enhancement in cerebrovascular disease.

Authors:  M Essig; R von Kummer; T Egelhof; R Winter; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  1996-05       Impact factor: 3.825

9.  MRI detection of early blood-brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis.

Authors:  Niels Hjort; Ona Wu; Mahmoud Ashkanian; Christine Sølling; Kim Mouridsen; Søren Christensen; Carsten Gyldensted; Grethe Andersen; Leif Østergaard
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

10.  Gadolinium-DTPA: a new contrast agent for magnetic resonance imaging.

Authors:  H P Niendorf; R Felix; M Laniado; W Schörner; C Claussen; H J Weinmann
Journal:  Radiat Med       Date:  1985 Jan-Mar
View more
  21 in total

Review 1.  In vivo methods to study uptake of nanoparticles into the brain.

Authors:  Inge van Rooy; Serpil Cakir-Tascioglu; Wim E Hennink; Gert Storm; Raymond M Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2010-10-07       Impact factor: 4.200

2.  The concordance of MRI and quantitative autoradiography estimates of the transvascular transfer rate constant of albumin in a rat brain tumor model.

Authors:  Ramesh Paudyal; James R Ewing; Tavarekere N Nagaraja; Hassan Bagher-Ebadian; Robert A Knight; Swayamprava Panda; Mei Lu; Karyn Ledbetter; Joseph D Fenstermacher
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

3.  MRI of blood-brain barrier permeability in cerebral ischemia.

Authors:  Quan Jiang; James R Ewing; Michael Chopp
Journal:  Transl Stroke Res       Date:  2012-03       Impact factor: 6.829

Review 4.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

5.  Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation.

Authors:  R E Thornhill; S Chen; W Rammo; D J Mikulis; A Kassner
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-25       Impact factor: 3.825

6.  A dual-labeled Annexin A5 is not suited for SPECT imaging of brain cell death in experimental murine stroke.

Authors:  Marietta Zille; Denise Harhausen; Marijke De Saint-Hubert; Roger Michel; Chris P Reutelingsperger; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-02       Impact factor: 6.200

7.  Porous Polymersomes with Encapsulated Gd-labeled Dendrimers as Highly Efficient MRI Contrast Agents.

Authors:  Zhiliang Cheng; Daniel L J Thorek; Andrew Tsourkas
Journal:  Adv Funct Mater       Date:  2009-12-09       Impact factor: 18.808

8.  MRI and quantitative autoradiographic studies following bolus injections of unlabeled and (14)C-labeled gadolinium-diethylenetriaminepentaacetic acid in a rat model of stroke yield similar distribution volumes and blood-to-brain influx rate constants.

Authors:  Tavarekere N Nagaraja; James R Ewing; Kishor Karki; Paul E Jacobs; George W Divine; Joseph D Fenstermacher; Clifford S Patlak; Robert A Knight
Journal:  NMR Biomed       Date:  2010-12-12       Impact factor: 4.044

9.  Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.

Authors:  Jaspreet Kaur; Ursula I Tuor; Zonghang Zhao; Philip A Barber
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-25       Impact factor: 6.200

10.  Multimodality imaging of blood-brain barrier impairment during epileptogenesis.

Authors:  Heike Breuer; Martin Meier; Sophie Schneefeld; Wolfgang Härtig; Alexander Wittneben; Martin Märkel; Tobias L Ross; Frank M Bengel; Marion Bankstahl; Jens P Bankstahl
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.